3-D Matrix, Ltd. (7777.T)
Tokyo · JPY · Healthcare · Medical Devices
¥361 (-0.28%) as of
Key statistics
- Market cap
- 46.20B
- P/E (TTM)
- 13.49
- Forward P/E
- -28.20
- EPS (TTM)
- 26.76
- Dividend yield
- 0.00%
- 52-week range
- 290.00 – 793.00
- Beta
- 0.99
- Revenue (TTM)
- 11.92B
- Profit margin
- 30.98%
- Volume
- 920.50k
About 3-D Matrix, Ltd.
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields; and surfactant-like peptide, as well as High Concentration PuraMatrix, a high concentration hydrogel; and GMP Grade PuraMatrix. The company was incorporated in 2004 and is based in Tokyo, Japan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Tokyo, Japan
- Employees
- 129
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.